Ignite Creation Date:
2024-05-06 @ 8:06 AM
Last Modification Date:
2024-10-26 @ 11:56 AM
Study NCT ID:
NCT02667587
Status:
COMPLETED
Last Update Posted:
2024-05-29
First Post:
2016-01-26
Brief Title:
An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo for Newly Diagnosed Patients With Glioblastoma GBM a Malignant Brain Cancer
Sponsor:
Organization:
Bristol-Myers Squibb